These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3774625)

  • 1. Pharmacokinetic and metabolic studies of vinpocetine on dogs. II. Metabolism.
    Szeleczky G; Vereczkey L
    Pol J Pharmacol Pharm; 1986; 38(3):269-75. PubMed ID: 3774625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and metabolic studies of vinpocetine on dogs. I. Pharmacokinetics.
    Szeleczky G; Vereczkey L
    Pol J Pharmacol Pharm; 1986; 38(3):257-67. PubMed ID: 3774624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic metabolism of vinpocetine in the rat.
    Vereczkey L; Szentirmay Z; Szporny L
    Arzneimittelforschung; 1979; 29(6):953-6. PubMed ID: 582790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of ethyl apovincaminate in the rat.
    Vereczkey L; Szporny L
    Arzneimittelforschung; 1976; 26(10a):1933-8. PubMed ID: 1037219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the absorption of vinpocetine and apovincaminic acid.
    Pudleiner P; Vereczkey L
    Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling.
    Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG
    Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
    Weinz C; Schwarz T; Kubitza D; Mueck W; Lang D
    Drug Metab Dispos; 2009 May; 37(5):1056-64. PubMed ID: 19196845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of apovincaminic acid in dogs.
    Vereczkey L; Pudleiner P
    Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biotransformation of the novel inotropic agent toborinone (OPC-18790) in rats and dogs. Evidence for the formation of novel glutathione and two cysteine conjugates.
    Kitani M; Miyamoto G; Nagasawa M; Yamada T; Matsubara J; Uchida M; Odomi M
    Drug Metab Dispos; 1997 Jun; 25(6):663-74. PubMed ID: 9193867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol.
    Kabuto S; Kimata H; Yonemitsu M; Koide T; Nakao H; Suzuki J
    Arzneimittelforschung; 1985; 35(11):1674-9. PubMed ID: 3937533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of vinpocetine (Cavinton) in dog.
    Polgár M; Vereczkey L
    Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(6):623-8. PubMed ID: 11985336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition and metabolism of finasteride in dogs.
    Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
    Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etofenamate fatty acid asters. An example of a new route of drug metabolism.
    Dell HD; Fielder J; Kamp R; Gau W; Kurz J; Weber B; Wuensche C
    Drug Metab Dispos; 1982; 10(1):55-60. PubMed ID: 6124384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies].
    Gulyás B; Halldin C; Karlsson P; Chou YH; Swahn CG; Bönöczk P; Farde L
    Orv Hetil; 1999 Jul; 140(30):1687-91. PubMed ID: 10461449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation of the organic nitrate trans-N-(4-nitroxycyclohexyl)acetamide in dogs.
    Zell C; Neidlein R; Strein K
    Arzneimittelforschung; 1994 Sep; 44(9):1021-8. PubMed ID: 7986238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolism of vincamine in the rat].
    Viganò V; Paracchini S; Piacenza G; Pesce E
    Farmaco Sci; 1978 Aug; 33(8):583-94. PubMed ID: 744256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolism and excretion of risperidone after oral administration in rats and dogs.
    Meuldermans W; Hendrickx J; Mannens G; Lavrijsen K; Janssen C; Bracke J; Le Jeune L; Lauwers W; Heykants J
    Drug Metab Dispos; 1994; 22(1):129-38. PubMed ID: 7512019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.